Guardant Health (NASDAQ: GH) reported Q4 EPS of ($0.94), $0.37 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $78.3 million versus the consensus estimate of $76.73 million.

GUIDANCE:

Guardant Health sees FY2021 revenue of $360-370 million, versus the consensus of $377.07 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.